CorMedix (CRMD) Profit After Tax (2010 - 2025)
CorMedix (CRMD) reported Profit After Tax of -$1.8 million for Q4 2025, down 90039.64% on a YoY basis from N/an in Q4 2024, and down 21891.59% sequentially from $8205.0 in Q3 2025.
CorMedix (CRMD) Profit After Tax (2010 - 2025) Analysis & Trends
CorMedix (CRMD) has 16 years of Profit After Tax data on file, last reported at -$1.8 million in Q4 2025.
- For the quarter ending Q4 2025, Profit After Tax fell 90039.64% year-over-year to -$1.8 million; the trailing twelve-month figure through Dec 2025 stood at -$1.8 million (up 89.43% YoY), and the FY2025 full-year result was -$88000.0, down 2833.33% from the prior year.
- Profit After Tax eased to -$1.8 million in Q4 2025, from $8205.0 in the prior quarter.
- In the past five years, Profit After Tax ranged from a high of $8205.0 in Q3 2025 to a low of -$14.7 million in Q4 2023.
- A 5-year average of -$6.1 million and a median of -$7.1 million in 2021 frame the typical range for Profit After Tax.
- Peak annual rise in Profit After Tax reached 100.3% in 2025, while the deepest fall reached 90039.64% in 2025.
- Tracing CRMD's Profit After Tax over 5 years: stood at -$7.8 million in 2021, then fell by 5.34% to -$8.2 million in 2022, then slumped by 79.63% to -$14.7 million in 2023, then jumped by 100.01% to $1988.0 in 2024, then plunged by 90039.64% to -$1.8 million in 2025.
- Business Quant data shows CRMD's Profit After Tax at -$1.8 million in Q4 2025, $8205.0 in Q3 2025, and -$5121.0 in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -36.84 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 227.36 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.03 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -65.60 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | -26.94 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 362.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -453.82 Mn |
| 10 | CorMedix | 546.82 Mn | 391.62 Mn | 107.31 Mn | -1.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -1.79 Mn |
| Sep 30, 2025 | 8,205.00 |
| Jun 30, 2025 | -5,121.00 |
| Mar 31, 2025 | -6,090.00 |
| Dec 31, 2024 | 1,988.00 |
| Sep 30, 2024 | -2.78 Mn |
| Jun 30, 2024 | -14.15 Mn |
| Mar 31, 2024 | -10,647.00 |
| Dec 31, 2023 | -14.74 Mn |
| Sep 30, 2023 | -9.75 Mn |
| Jun 30, 2023 | -11.27 Mn |
| Mar 31, 2023 | -10.55 Mn |
| Dec 31, 2022 | -8.21 Mn |
| Sep 30, 2022 | -6.85 Mn |
| Jun 30, 2022 | -7.60 Mn |
| Mar 31, 2022 | -7.07 Mn |
| Dec 31, 2021 | -7.79 Mn |
| Sep 30, 2021 | -8.57 Mn |
| Jun 30, 2021 | -4.63 Mn |
| Mar 31, 2021 | -7.22 Mn |